ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.790
+0.060 (3.47%)
Nov 21, 2024, 12:35 PM EST - Market open
ESSA Pharma Employees
ESSA Pharma had 50 employees as of September 30, 2023. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$553,379
Market Cap
79.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
P3 Health Partners | 400 |
I-Mab | 220 |
CASI Pharmaceuticals | 176 |
OptimizeRx | 136 |
Chimerix | 72 |
Aerovate Therapeutics | 51 |
Quince Therapeutics | 32 |
Clearside Biomedical | 30 |
EPIX News
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ESSA Pharma Inc. (EPIX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 16 days ago - ESSA Pharma Inc. (EPIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Investors to Connect - Accesswire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating ESSA Pharma Inc. (EPIX) And Encourages Stockholders to Connect - Accesswire
- 19 days ago - ESSA Pharma Inc. (EPIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 20 days ago - ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer - PRNewsWire
- 2 months ago - ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress - PRNewsWire
- 2 months ago - ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference - PRNewsWire